Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

4 results
12:00 AM, Apr 20, 2015  |  BC Week In Review | Company News  |  Deals

Can-Fite, Cipher deal

finished product to Cipher. Cipher said it sees CF101 as being complementary to the company’s Beteflam Patch
12:00 AM, Mar 16, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Beteflam Patch regulatory update

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga …
deal granting Cipher marketing rights to the product in Canada (see BioCentury, Aug. 13, 2012). Beteflam Patch
self-adhesive medicated plaster containing 0.1% betamethasone valerate. Institut Biochimique S.A. , Lugano, Switzerland   Product: Beteflam Patch
12:00 AM, Oct 01, 2012  |  BioCentury | Finance

3Q Stock Wrap-Up: Back in black

active rheumatoid arthritis (RA) Submit MAA and BLA 4Q12 Cipher Pharmaceuticals Inc. (TSX:DND)/Institut Biochimique S.A. Betesil Patch
12:00 AM, Aug 13, 2012  |  BC Week In Review | Company News  |  Sales & Marketing

Cipher, Institut Biochimique sales and marketing update

Cipher received exclusive Canadian rights to market Institut's Betesil Patch to treat inflammatory skin conditions, including plaque …